Suppression of tumor necrosis factor-α and inducible nitric oxide synthase gene expression by THI 52, a new synthetic naphthyl-benzylisoquinoline alkaloid
- 1 February 2003
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 65 (3) , 457-464
- https://doi.org/10.1016/s0006-2952(02)01549-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS 49, in rat vascular smooth muscle and RAW 264.7 macrophagesBritish Journal of Pharmacology, 1999
- Tetrandrine Inhibits Signal-Induced NF-κB Activation in Rat Alveolar MacrophagesBiochemical and Biophysical Research Communications, 1997
- Altered immune responses in mice lacking inducible nitric oxide synthaseNature, 1995
- Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthaseCell, 1995
- Inhibitory effect of bisbenzylisoquinoline alkaloids on nitric oxide production in activated macrophagesBiochemical Pharmacology, 1993
- Inhibitory Action of Tetrandrine on Macrophage Production of Interleukin-1 (IL-l)-Like Activity and Thymocyte ProliferationExperimental Lung Research, 1992
- Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivoEuropean Journal of Pharmacology, 1990
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Studies of the chronic toxicity of tetrandrine in dogs: An inhibitor of silicosisEcotoxicology and Environmental Safety, 1982
- Intrinsic dichlorophenolindophenol reductase activity associated with the superoxide-generating oxidoreductase of human granulocytesBiochemistry, 1981